REPRAT 20MG GASTRO RESISTANT TABLET

Țară: Cipru

Limbă: greacă

Sursă: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Ingredient activ:

PANTOPRAZOLE SODIUM SESQUIHYDRATE

Disponibil de la:

DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629

Codul ATC:

A02BC02

INN (nume internaţional):

PANTOPRAZOLE

Dozare:

20MG

Forma farmaceutică:

GASTRO RESISTANT TABLET

Compoziție:

PANTOPRAZOLE SODIUM SESQUIHYDRATE (8000001653) 22,575MG

Calea de administrare:

ORAL USE

Tip de prescriptie medicala:

Εθνική Διαδικασία

Zonă Terapeutică:

PANTOPRAZOLE

Rezumat produs:

Νομικό καθεστώς: Χωρίς Ιατρική Συνταγή Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 7 TABS IN BLISTER(S) (300010301) 7 TABLET - Εγκεκριμένο - Χωρίς Ιατρική Συνταγή; PACK WITH 10 TABS IN BLISTER(S) (300010302) 10 TABLET - Εγκεκριμένο - Χωρίς Ιατρική Συνταγή; PACK WITH 14 TABS IN BLISTER(S) (300010303) 14 TABLET - Εγκεκριμένο - Χωρίς Ιατρική Συνταγή; PACK WITH 20 TABS IN BLISTER(S) (300010304) 20 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 30 TABS IN BLISTER(S) (300010305) 30 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται

Prospect

REPRAT 20 - COMPARATIVE TABLE PIL-EN VS PIL-GR
PACKAGE LEAFLET: INFORMATION FOR THE USER
REPRAT 20 MG GASTRO-RESISTANT TABLETS
pantoprazole
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
Always take this medicine exactly as described in this leaflet or as
your
doctor, pharmacist or nurse have told you.
-
Keep this leaflet. You may need to read it again.
-
Ask your pharmacist if you need more information or advice.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in this leaflet.
See
section 4.
-
You must talk to your doctor if you do not feel better or if you feel
worse.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ: ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ
ΤΟΝ ΧΡΉΣΤΗ
REPRAT 20 MG ΓΑΣΤΡΟΑΝΘΕΚΤΙΚΆ ΔΙΣΚΊΑ
παντοπραζόλη
ΔΙΑΒΆΣΤΕ ΠΡΟΣΕΚΤΙΚΆ ΟΛΌΚΛΗΡΟ ΤΟ ΦΎΛΛΟ
ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ ΠΡΙΝ ΑΡΧΊΣΕΤΕ
ΝΑ ΠΑΊΡΝΕΤΕ ΑΥΤΌ ΤΟ
ΦΆΡΜΑΚΟ,
ΔΙΌΤΙ
ΠΕΡΙΛΑΜΒΆΝΕΙ
ΣΗΜΑΝΤΙΚΈΣ
ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΣΑΣ.
Πρέπει πάντοτε να παίρνετε αυτό το
φάρμακο ακριβώς όπως περιγράφεται
στο παρόν φύλλο οδηγιών χρήσης ή
σύμφωνα με τις οδηγίες του γιατρού,
του
φαρμακοποιού ή του νοσοκόμου σας.
-
Φυλάξτε
αυτό
το φύλλο
οδηγιών
χρήσης.
Ίσως
χρειαστεί
να το
διαβάσετε ξανά.
-
Απευθυνθείτε στον φαρμακοποιό σας εάν
χρειαστείτε περισσότερες
πληροφορίες ή συμβουλές.
-
�

Caracteristicilor produsului

1.
NAME OF THE MEDICINAL PRODUCT
Reprat 20 mg Gastro-resistant tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 20 mg pantoprazole as pantoprazole sodium
sesquihydrate.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Gastro-resistant tablets
Reprat 20 mg tablets are oval, yellow coloured gastro-resistant coated
tablets.
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Reprat is indicated for use in adults and adolescents 12 years of age
and above for:

Symptomatic gastro-oesophageal reflux disease.

Long-term management and prevention of relapse in reflux oesophagitis.
Reprat is indicated for use in adults for:

Prevention of gastroduodenal ulcers induced by non-selective
non-steroidal anti-inflammatory
drugs (NSAIDs) in patients at risk with a need for continuous NSAID
treatment (see section
4.4).
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults and adolescents 12 years of age and above
Symptomatic gastro-oesophageal reflux disease
The recommended oral dose is one Reprat 20 mg tablet per day. Symptom
relief is generally
accomplished within 2-4 weeks. If this is not sufficient, symptom
relief will normally be achieved
within a further 4 weeks. When symptom relief has been achieved,
reoccurring symptoms can be
1
SUMMARY OF PRODUCT CHARACTERISTICS
controlled using an on-demand regimen of 20 mg once daily, taking one
tablet when required. A
switch to continuous therapy may be considered in case satisfactory
symptom control cannot be
maintained with on-demand treatment.
Long-term management and prevention of relapse in reflux oesophagitis
For long-term management, a maintenance dose of one Reprat 20 mg
tablet per day is
recommended, increasing to 40 mg pantoprazole per day if a relapse
occurs. Reprat 40 mg is
available for this case. After healing of the relapse the dose can be
reduced again to Reprat 20 mg
tablet.
Adults
Prevention of gastroduodenal ulcers induced by non-selective
non-steroidal anti-inflammatory
drugs (NSAIDs) in patients at risk